Investor's Business Daily96d agobearish
Why Gilead's High-Profile HIV Drug Might Have To Play Catch-UpNotícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
102last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Barrons.com185d agobearish
Gilead Earnings Show HIV Drugs Continue to Shine. Why the Guidance Cut?Reuters185d agobearish
Gilead raises 2026 sales forecast, cuts profit outlook due to acquisitions